301290 东星医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.831-1.7274.3444.3896.255
总资产报酬率 ROA (%)0.741-1.5453.9964.0705.651
投入资产回报率 ROIC (%)0.778-1.6444.2484.3406.179

边际利润分析
销售毛利率 (%)50.22748.58949.36648.28052.276
营业利润率 (%)23.742-6.82326.55626.97626.787
息税前利润/营业总收入 (%)24.254-6.79325.93524.57526.422
净利润/营业总收入 (%)19.362-10.29622.25023.02823.460

收益指标分析
经营活动净收益/利润总额(%)64.451-182.12066.51769.86493.788
价值变动净收益/利润总额(%)34.826-102.01825.80716.5072.377
营业外收支净额/利润总额(%)-0.9164.126-0.5040.0491.161

偿债能力分析
流动比率 (X)6.7405.7356.79211.4309.209
速动比率 (X)6.2125.2946.26010.6248.589
资产负债率 (%)9.67811.2839.2206.1577.553
带息债务/全部投入资本 (%)5.6385.8662.2620.4590.071
股东权益/带息债务 (%)1,662.1421,593.3434,283.44121,503.312139,494.753
股东权益/负债合计 (%)930.307783.672981.5591,519.0981,217.047
利息保障倍数 (X)33.325-20.943-53.164-10.176-38.854

营运能力分析
应收账款周转天数 (天)85.24079.75878.05992.97090.424
存货周转天数 (天)229.022203.770174.865162.681163.882